Panelists discuss how early screening, timely intervention, and the use of teplizumab can improve outcomes for individuals with type 1 diabetes (T1D) by delaying disease progression and reducing complications like diabetic ketoacidosis.
Using new treatment advances, traditional medications, genetic profiles, immunotherapies, and individualized plans enables providers to improve outcomes for patients with TPBC.
Shop the latest in Dermatology from authors such as Bolognia and Habif, covering clinical dermatology, dermoscopy, & dermatopathology + free shipping!
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
American Family Physician Community Blog, Diagnosing Acute Bacterial vs Viral Rhinosinusitis, written by Lilian White, MD.
Steven Pipe, MD, explains the long-term efficacy data surrounding etranacogene dezaparvovec in patients with hemophilia B.
Panelists at the 2025 ASCO Genitourinary Cancers Symposium discussed challenges and new approaches to treatment.
Background: Cell-free DNA blood tests (cf-bDNA) and next-generation stool tests could change colorectal cancer (CRC) screening. Objective: To estimate the clinical and economic impacts of…
Objective Complete congenital heart block (CHB) due to anti-Ro/La antibodies in pregnancy can lead to adverse fetal outcomes and neonatal death. National and international guidelines…
Objective The primary objective of this study was to assess the prescribing patterns of long acting injectable (LAI) antipsychotics in an older adult population. Secondary…
Water makes up between 50% and 70% of your body weight. It’s essential for every cell, tissue and organ in your body. Water removes waste…
